Pull to refresh
Logo
U.S. Department of Health and Human Services (HHS)

U.S. Department of Health and Human Services (HHS)

Federal Cabinet Department

Appears in 16 stories · Last updated Nov 9, 2026

Stories

Kentucky opens LIHEAP fall heating aid enrollment for Jefferson County

Money Moves

Funds LIHEAP through block grants

Jefferson County households can begin applying Nov. 9 for Kentucky's LIHEAP Fall Subsidy, a one-time credit toward winter heating bills. Enrollment runs through Dec. 18, or until the designated funds are spent.

Updated 2 days ago

FDA proposes first infant formula nutrient update since 1998

Rule Changes

Oversees the FDA and publicized the proposal

The Food and Drug Administration proposed new nutrient limits for infant formula on October 29, 2026, the first comprehensive rewrite since 1998. The proposal changes four of the 30 required nutrients: it triples the iodine minimum, doubles the vitamin D minimum, lowers the vitamin A ceiling, and sets a first manganese cap.

Updated 7 days ago

HHS will let compounding pharmacies make six unapproved peptides

Rule Changes

Posted the enforcement-discretion policy

Patients who buy peptide injections online for muscle growth, injury healing and longevity may soon find them at a local pharmacy. Health and Human Services posted a draft policy on October 28 saying it will not penalize small compounding pharmacies that make six peptides the Food and Drug Administration has never approved.

Updated Oct 31

Federal newborn essentials program goes nationwide, starting with West Virginia

New Capabilities

Leads the NEST program

West Virginia is the first state to receive kits under the national expansion of the Newborn Essentials Support Toolkit, run by the Department of Health and Human Services. About 2,000 kits are expected in the first phase, handed out through WVU Medicine and other health systems, including Valley Health, which joined as a partner on October 12.

Updated Oct 27

ARPA-H launches SPECTRA, an AI-driven initiative to transform autism diagnosis

New Capabilities

Parent agency of ARPA-H

The first SPECTRA deadline has passed. Solution summaries for Technical Area 4, the enabling-technologies track, closed October 21 at 3 p.m. ET, three days later than the original October 18 date, and ARPA-H's program page now lists the track as closed to new submissions.

Updated Oct 22

HHS finalizes overhaul of health insurance price transparency rules

Rule Changes

Lead agency finalizing the rule

Health insurers must publish their negotiated rates in a form researchers and consumers can use. The Department of Health and Human Services finalized the updates to the Transparency in Coverage rules on October 5, 2026, with the Departments of Labor and the Treasury.

Updated Oct 21

HHS launches vaccine injury research and reporting initiative

Rule Changes

Leading the vaccine injury initiative

The federal government opened a dedicated clinic at the National Institutes of Health this month to study and treat people reporting health problems after vaccination. It's the centerpiece of a new agency-wide push by the Department of Health and Human Services (HHS) to document, investigate, and respond to vaccine injuries. An internal memo obtained by NPR says NIH plans an observational study of vaccinated people and possible complications, and may examine vaccine schedules and treatments.

Updated Oct 17

FDA launches pilot to speed up early-stage drug trials

Rule Changes

As of October 2026: Parent agency running Operation TrialBlazer

The FDA stopped taking applications on October 30 for its pilot aimed at speeding first-in-human drug trials. The agency expects to name eight to ten drugmakers, each paired with a research institution, by December 18.

Updated Oct 4

HHS drops $10 billion funding freeze against five Democratic-led states

Rule Changes

As of July 2026: Imposed and then rescinded the freeze

The Department of Health and Human Services ended its six-month freeze on $10 billion in child care and family-aid money for five states on July 14. The funds, meant for low-income families in California, Colorado, Illinois, Minnesota, and New York, are flowing again.

Updated Jul 15

FDA approves leucovorin for ultra-rare brain disorder, declines autism indication promoted by White House

Rule Changes

As of May 2026: Promoted leucovorin for autism; FDA approval did not match its claims

In September 2025, White House officials told parents of autistic children that a cheap, generic drug called leucovorin might improve their children's speech and behavior. Prescriptions surged 71% in the following months, pharmacies ran dry, and the Food and Drug Administration (FDA) allowed emergency imports from Canada and Spain. On March 10, 2026, the FDA approved leucovorin — but only for a genetic condition so rare that fewer than 50 cases have ever been identified worldwide, not for autism.

Updated May 30

Reshaping federal health leadership

Rule Changes

As of May 2026: Led by Secretary Robert F. Kennedy Jr.

Jay Bhattacharya co-authored the Great Barrington Declaration in October 2020, publicly opposing the Centers for Disease Control and Prevention's pandemic response policies. Five years later, he now controls both the CDC and the National Institutes of Health—the two largest federal public health agencies—making him the most powerful health official in America outside the cabinet.

Updated May 29

Federal pressure shutters pediatric gender clinics nationwide

Rule Changes

As of May 2026: Driving enforcement effort through declarations, investigations, and proposed rules

Lurie Children's Hospital, which opened the Midwest's first pediatric gender identity clinic in 2013, announced it will no longer prescribe gender-affirming medications to new patients under 18. This came days after HHS General Counsel Mike Stuart referred the hospital for federal investigation.

Updated May 22

Minnesota's billion-dollar welfare fraud crisis

Force in Play

As of May 2026: Froze $185M in Minnesota child care funding

On January 5, 2026, Governor Tim Walz announced he would drop his bid for a third term. The reversal came just two days before a contentious January 7 House Oversight Committee hearing where Republican state lawmakers testified that Walz and Attorney General Keith Ellison ignored widespread fraud and silenced whistleblowers.

Updated May 21

Trump orders a fast-track marijuana reschedule to Schedule III—reviving a stalled Biden-era process

Rule Changes

As of May 2026: Provided scientific/medical recommendation and is tasked with expanded research models

Trump's executive order instructing DOJ to fast-track marijuana's move to Schedule III immediately triggered a familiar split. Public health and industry groups cheered the potential research and tax impacts, while House Republicans organized opposition, urging Trump to keep marijuana in Schedule I.

Updated May 15

The U.S. closes the legal door on 4-CMC—five years after the UN did

Rule Changes

As of May 2026: Provided scientific/medical evaluation and scheduling recommendation to DEA

4-CMC is one of those modern drug-market products built for speed: cheap, tweakable chemistry that can be sold as a "new" stimulant the moment the old one gets banned. On December 17, 2025, the U.S. finally snapped the trap shut—DEA's Schedule I controls for 4-CMC took effect nationwide.

Updated May 15

ACIP moves to end universal hepatitis B shots at birth

Rule Changes

As of May 2026: Political driver of ACIP restructuring and vaccine-schedule review

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 8–3 on December 5, 2025 to end the recommendation that every U.S. newborn receive a hepatitis B shot within 24 hours of birth. The committee had been recently overhauled under HHS Secretary Robert F. Kennedy Jr.; acting CDC Director Jim O'Neill ratified the change on December 16, 2025.

Updated May 9